BioSpace News Archive

Biotech Bay

The Top 5 Genome Sequencing Companies by Revenue

The gene sequencing industry has really taken off in recent years. Here’s a look at the top five genome sequencing companies, ranked by revenue.

April 17, 2019
·
4 min read
·
Franklin Carpenter
Drug Development

AveXis’ Phase III Data Provides More Ammo for Benefit of SMA Gene Therapy

AveXis, a Novartis company, announced interim data from its Phase III STR1VE clinical trial of Zolgensma (onasemnogene abeparvovec-xioi) in spinal muscular atrophy (SMA) Type 1.

April 17, 2019
·
3 min read
·
Mark Terry
Drug Development

Polyphor announces enrollment of first patient in PRISM-UDR - the second, FDA agreed - Phase III clinical trial for murepavadin in patients with nosocomial pneumonia

Murepavadin is the lead, pathogen specific, Phase III antibiotic belonging to the OMPTA family and potentially the first drug of a new class of antibiotics against Gram-negative bacteria in more than 50 years

April 17, 2019
·
4 min read
Deals

CEVEC closes major financing round to further expand and commercialize its viral vector manufacturing platform

CEVEC Pharmaceuticals GmbH announced the successful closing of a Series D financing round with new and existing investors.

April 17, 2019
·
3 min read
TreeFrog Therapeutics delivers first batch of Stem Cells (hIPS), with best-in-class quality check, to cell and gene therapy leader Imagine Institute

Based on biomimetic stem cell culture in 3D, C-Stem™ enables cell therapy production scale-up while ensuring genomic and phenotypic stability

April 17, 2019
·
3 min read
FDA

Ultragenyx Announces UX007 Granted Fast Track Designation and Rare Pediatric Disease Designation by U.S. FDA for Treatment of Long-Chain Fatty Acid Oxidation Disorders

Company on Track to Submit NDA to FDA in Mid-2019

April 17, 2019
·
5 min read
Policy

Bioprinting: Poietis announces the award of a third new major European patent

Poietis, 4D Bioprinting company, announces the issuance by the European Patent Office of a third patent covering its bioprinting technology

April 17, 2019
·
2 min read
Pharm Country

Lannett Shares Fall After Article Raises Questions Regarding Anti-Trust Lawsuits and Potential Fines

The pseudonym-penned article contends 2013 and 2014 price increases for two Lannett Drugs were part of a multi-company price-fixing scheme.

April 17, 2019
·
2 min read
·
Alex Keown
FDA

Circassia Pharma Receives 2nd FDA Approval for COPD Treatment in 2 Weeks

COPD is a progressive disease associated with tobacco smoking, air pollution or occupational exposure. It results in difficulties in breathing and increasing episodes of breathlessness.

April 17, 2019
·
3 min read
·
Mark Terry
Deals

Notice of Annual General Meeting in Promore Pharma AB (publ)

Promore Pharma AB calls for Annual General Meeting Tuesday 21 May 2019 at 2 pm at Wenner-Gren Center, Biblioteket, plan 24, Sveavägen 166, in Stockholm.

April 17, 2019
·
8 min read